Ruth Berry

Director, Analytical Development Strategy @ GentiBio arrow icon

About Ruth Berry

Ruth Berry is the Director of Analytical Development Strategy and holds a PhD.

Known information

Ruth Berry serves as the Director of Analytical Development Strategy, a role that involves overseeing and guiding the strategic direction of analytical development within her organization. She holds a PhD, indicating a high level of expertise and specialization in her field. Her position likely requires a deep understanding of analytical methodologies and the ability to integrate these strategies effectively to support the organization’s goals.

About GentiBio

GentiBio is a biotech company focused on developing engineered T regulatory cell therapies for various immune and inflammatory diseases, with its lead product GNTI-122 targeting type 1 diabetes.

report flag Report inaccurate information

People similar to Ruth Berry

Rebecca Brunette

Associate Director, Product Sciences and Characterization @ GentiBio

Rebecca Brunette is the Associate Director of Product Sciences and Characterization, holding a PhD in her field.

Alberto del Rio Espinola

Director, Translational Sciences @ GentiBio

Alberto del Rio Espinola is the Director of Translational Sciences and holds a PhD.

Mirna Mujacic

VP, Process and Analytical Development @ GentiBio

Mirna Mujacic is the Vice President of Process and Analytical Development and holds a PhD.

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free